See more : Innovid Corp. (CTV) Income Statement Analysis – Financial Results
Complete financial analysis of Nouveau Life Pharmaceuticals, Inc. (NOUV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nouveau Life Pharmaceuticals, Inc., a leading company in the Shell Companies industry within the Financial Services sector.
- Abacus Storage King (ASK.AX) Income Statement Analysis – Financial Results
- HOCHTIEF Aktiengesellschaft (HOT.SW) Income Statement Analysis – Financial Results
- ChargePanel AB (publ) (CHARGE.ST) Income Statement Analysis – Financial Results
- Digital China Holdings Limited (910861.TW) Income Statement Analysis – Financial Results
- NuScale Power Corporation (SMR-WT) Income Statement Analysis – Financial Results
Nouveau Life Pharmaceuticals, Inc. (NOUV)
Industry: Shell Companies
Sector: Financial Services
About Nouveau Life Pharmaceuticals, Inc.
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. It provides natural alternatives and prescription drugs. The company was formerly known as Hybrid Fuels, Inc. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 2012. Nouveau Life Pharmaceuticals, Inc. was incorporated in 1998 and is based in Ft. Lauderdale, Florida. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc.
| Metric | 2022 | 2021 | 2020 | 2019 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.93K | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 160.50K | 176.84K | 318.01K | 220.44K | 180.11K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 357.25K | 267.32K | 318.01K | 229.36K | 180.11K |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 357.25K | 267.32K | 318.01K | 229.36K | 180.11K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 133.84K | 53.00K | 113.80K | -458.72K | -360.17K |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -213.91K | -213.25K | -199.69K | -229.36K | -180.05K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 357.25K | 267.32K | 318.01K | 229.36K | 180.11K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -9.50K | -1.07K | 46.18K | -4.52K | -60.00 |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | 347.75K | 266.25K | 313.49K | 0.00 | 180.05K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -10.50K | 83.43K | 541.61K | 434.05K |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | -357.25K | -256.82K | -401.43K | -312.25K | -254.00K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 28.31M | 25.94M | 24.33M | 22.35M | 21.60M |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 28.31M | 25.94M | 24.33M | 22.35M | 21.60M |
Source: https://incomestatements.info
Category: Stock Reports